Rowex launches OTC sumatriptan in Ireland
This article was originally published in OTC Bulletin
Executive Summary
Migraine sufferers in Ireland will for the first time be able to access a sumatriptan product without a prescription thanks to the OTC launch of Rowex’s Sumatran Relief.
You may also be interested in...
Second Time Lucky? Sumatriptan One Of Three Switches On The Cards In Germany
A second attempt at switching sumatriptan for migraines, as well as switch applications for non-steroidal anti-inflammatories ketoprofen and liquid ibuprofen, are all on the agenda at Germany's next Expert Committee for Prescription meeting in June.
An Expert’s Guide To Switching In Germany, Part 1: Navigating The Reclassification Process
Elmar Kroth, scientific director of the German Medicines Manufacturers´ Association, the BAH, talks exclusively to HBW Insight about prescription-to-OTC switching in Germany and the association’s efforts to improve this process.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”